It has a state of the art molecular diagnostics department with accreditation from NABL and approval from ICMR, to start full-fledged testing of COVID-19 RT-PCR confirmatory test which remains a Gold Standards for Covid-19 testing.
The announcement comes at a time when Bengaluru is preparing to emerge from the lockdown and testing becomes essential to control the spread of Covid-19 infection through fast identification, quarantine, isolation and treatment.
“We at Aster Labs remain committed to protect India, as the country battles the COVID-19 pandemic. We are proud to contribute our scientific expertise and resources in supporting the nation in this hour of need,” said Dr. Harish Pillai, CEO of Aster India.
Aster DM Healthcare shares were flat at the close of the market selling Rs96.05 down 0.60 or 0.62% at the BSE.